All posts by medical

Where math meets biology – Penn: Office of University Communications

Open any biology textbook and it becomes instantly clear that this area of study is incredibly complex. From the atomic-level structure of DNA to the relationships between prey and predator populations, biology encompasses an incredibly broad spectrum of molecules, organisms, and systems, all of which scientists are trying to understand in detail.

Yoichiro Moris career is focused on developing mathematical solutions to help address unanswered questions in biology and, in turn, to invigorate mathematics by introducing new questions inspired by biological problems. His research demonstrates how a fundamental mathematical understanding can provide new insights into complex systems and lead to new theoretical developments. Now, as the Calabi-Simons Visiting Professorof Mathematics and Biology, he aims to foster connections between researchers at Penn.

Moris latest research, published in the Proceedings of the National Academy of Sciences, stems from his interest in cell movement. Biologists have studied how cells rearrange their cytoskeleton, internal filaments that give cells structure, and use mechanical forces to move themselves forward. But theres a second force always acting on cells whose role in movement is less understood: osmosis. Osmotic and ionic regulation is a key component of cell biology, but biologists have yet to figure out if it could also play a role in how cells move.

Through a combination of experiments, conducted by collaborators at Johns Hopkins University, and mathematical models, the researchers found that its more advantageous for cells to use their osmosis-powered engines to move when they are in environments with high mechanical resistance, or where the space is crowded by cells or particles. They also found that having a cell membrane thats permeable to water also helped cells move more easily.

This paper is also one of the few studies that could directly compare osmotic engines with cell movement powered by the cytoskeleton, thanks in part to Moris previous work on how cells control their size. Mori was able to apply the thermodynamic framework to this problem, a technique that could be extended to other areas of biology in the future.

Despite his success in using math to help solve biological problems, Mori tries to stay humble. There are a lot of interesting biological questions, but many questions are not inherently mathematical, he says. Part of the challenge is that many systems in biology are quite complicated, especially compared to other natural sciences, like physics, where systems can be modeled more easily. Biology data are also more variable, and there is more uncertainty about how systems actually work.

Science has different phases, Mori explains. At the beginning you have to name things; the first thing is to list everything, and its only then that you can start to understand relationships. Most of biology up to the end of the 20th century was spent on naming things, but with molecular biology we can now start talking about relationships. Now, mathematics can start to play an important role.

Moris own unique academic path has also helped him see firsthand the role of math in biology. While attending medical school at the University of Tokyo, he realized that his passion for math and physics was stronger than for clinical medicine or benchtop research. After finishing his board exams, he made the seemingly unorthodox decision to join a Ph.D. program in mathematics at New York University. I have a lot of respect for experimentalists, in particular because I failed so miserably, says Mori. I found that scribbling equations on paper is the only thing I can actually do, and what I do is comparatively quite easy.

As the Calabi-Simons Visiting Professor, and co-director of the Center for Mathematical Biology, Mori aims to promote this area of research at Penn by bringing together faculty, graduate students, and researchers working at the interface of fundamental mathematics and other fields in the natural sciences like biology and medicine.

Theres so much exciting science going on in every corner of Penn, and I think there can be some really interesting collaborations and synergies, says Mori, adding that Penns strong history in soft condensed matter physics and the research portfolio of the medical school will also be instrumental in his own work on mathematical physiology and biophysics.

Mori also emphasizes Penns collaborative spirit as essential for future progress in this field. What I found through the years is that if you want to do really interesting things, you dont just sit in your office and think, you have to go talk to people. Getting ideas from other people, sharing your ideas with other people, and working with people are essential.

This research was supported by National Science Foundation Grant DMS-1620316.

Yoichiro Mori is the Calabi-Simons Visiting Professor ofMathematics and Biology with appointments in the Department of Mathematics and the Department of Biology in the School of Arts and Sciences at the University of Pennsylvania.

See the original post here:
Where math meets biology - Penn: Office of University Communications

Aiming to to Form Biological Patterns, Scientists Dissect and Redesign Protein-Based Pattern Formation – SciTechDaily

Different patterns formed by the teams minimal biochemical interaction networks. The modular replacements for MinE create this diverse set of patterns when co-reconstituted with MinD on membranes. Credit: Glock et al. CC BY 4.0

Probing the functional segments, or motifs, of proteins has helped scientists identify the minimal ingredients needed for them to form biological patterns.

Writing in the journal eLife, the researchers describe how they dissected the biological phenomenon of protein pattern formation into its main functional modules, and then rebuilt the process from the ground up in a completely new way.

Proteins self-organize to form patterns in living cells, which are essential for key functions such as cell division, communication, and movement. A striking example is the MinDE system of the bacterium Escherichia coli (E. coli). This system produces oscillations of two protein types, MinD and MinE, between two poles of the rod-shaped bacteria, positioning the machinery for cell division to midcell. It can be reconstituted in the laboratory, allowing scientists to control and manipulate the functional elements needed for pattern formation via protein mutations.

Because of its simplicity, the MinDE system has been invaluable in understanding the mechanisms of protein-based pattern formation, says Philipp Glock, a Ph.D. student at the Max Planck Institute of Biochemistry in Munich, Germany, and co-lead author alongside Fridtjof Brauns and Jacob Halatek, both from the Ludwig Maximilians University of Munich. A key question that remains is whether this structural and functional complexity can be reduced further to reveal a set of minimal ingredients for pattern formation.

To answer this, Glock and his colleagues created a minimalistic version of MinE, which plays an antagonistic role in the two-protein MinDE system, by dissecting the protein in a set of core functional motifs, guided by theoretical modeling. One motif, the short helical sequence of amino acids which MinE uses to interact with MinD, is not enough to produce patterns on its own. But adding other functional motifs of MinE one at a time enabled the scientists to fully design new minimal pattern-forming protein mutants.

The team found that at least one other functional motif is required to form patterns. This can either be a motif for membrane binding or a dimerizing motif, which binds to other molecules of the same kind. Neither of these motifs needs to be from native MinE, but can be replaced and potentially simplified further.

Mathematical modeling then allowed the authors to explain why these features are required and how they enable patterns to form. Moreover, they predicted how these patterns adapt to the cell shape in E. coli. The team says that testing these predictions is an exciting goal for future experiments.

Our work provides a starting point for a modular and tunable experimental platform to design protein-based pattern formation from the bottom-up, says Petra Schwille, PhD, Director of the Department of Cellular and Molecular Biophysics at the Max Planck Institute of Biochemistry, and co-senior author alongside theoretical physicist Erwin Frey, from the Ludwig Maximilians University of Munich. She adds that while the patterns created by the new system are less regular than those formed by the native MinDE system, they are still sufficient for reproducing and studying basic biological processes.

The model can now be used to study which functional features, regardless of a particular protein system, need to be combined to allow for self-organization and pattern formation in biology. Our modular approach may also provide the necessary data for computer modeling of pattern formation in other types of bacteria, as well as more complex organisms, Schwille concludes.

Reference: Design of biochemical pattern forming systems from minimal motifs by Philipp Glock, Fridtjof Brauns, Jacob Halatek, Erwin Frey and Petra Schwille, 26 November 2019, eLife.DOI: 10.7554/eLife.48646

Follow this link:
Aiming to to Form Biological Patterns, Scientists Dissect and Redesign Protein-Based Pattern Formation - SciTechDaily

Live Cell Imaging Market 2019 Research Report Overview by Top Key Players, Opportunities, Key Drivers, Application and Regional Outlook To 2027 -…

Global Live Cell Imaging Industry Analysis of the value chain helps to analyze major raw materials, major equipment, production processes, customer analysis and major Live Cell Imaging Market distributors. A comprehensive analysis of the statistics, market share, performance of the company, historical analysis Till 2018, volume, revenue, growth rate of YOY and CAGR forecast for 2027 is included in the report. Research Report also provides explicit information in recent years on mergers, acquisitions, joint ventures and other important market activities. Research Analysis report also provides Porter analysis, PESTEL analysis and market attractiveness to better understand the macro-and micro-level market scenario. Live Cell Imaging report also includes a detailed description, a competitive scenario, a wide range of market leaders and business strategies adopted by competitors with their analysis of SWOT.

Get the inside scope of the Sample report @https://www.theinsightpartners.com/sample/TIPHE100001215/

MARKET INTRODUCTION

Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes. This method is used by the scientists to obtain a better view of the cells biological function by studying the cellular dynamics. In recent years, live cell imaging technology has been widely accepted by various researchers to obtain a better knowledge regarding cell biology. Live cell imaging plays a crucial role in research fields such as neurology, immunology, microbiology and, genetics among others.

MARKET DYNAMICS

Rise in the number of cancer cases along with increase in the number of government funds for R&D activities are expected to be the driving factor in the market in the future years. Use of live cell imaging in the field of personalized medicine is expected to provide growth opportunities in the live cell imaging market during the forecast period.

The report also includes the profiles of key live cell imaging market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Key Competitors In Market are

TOC pointsof Market Report:

Market size & shares

Market trends and dynamics

Market Drivers and Opportunities

Competitive landscape

Supply and demand

Technological inventions in industry

Marketing Channel Development Trend

Market Positioning

Pricing Strategy

Brand Strategy

Target Client

MARKET SCOPE

The Global Live Cell Imaging Market Analysis to 2027 is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of live cell imaging market with detailed market segmentation by product, technology, application, end users and geography. The global live cell imaging market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading live cell imaging market players and offers key trends and opportunities in the market.

Market segmentation:

Live Cell Imaging Market to 2027 Global Analysis and Forecasts By Product (Equipment, Kits and Reagents, Software, Consumables); Technology (Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High-content Analysis, Fluorescence In Situ Hybridization, Others); Application (Drug Discovery, Cell Biology, Developmental Biology,, Stem Cells, Others); End User (Pharmaceutical & Biotechnology Companies, Hospitals, Diagnostic Laboratories, Others) and Geography

By Geography North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. And 13 countries globally along with current trend and opportunities prevailing in the region.

The target audience for the report on the market

Manufactures

Market analysts

Senior executives

Business development managers

Technologists

R&D staff

Distributors

Investors

Governments

Equity research firms

Consultants

Click to buy full report with all description:-https://www.theinsightpartners.com/buy/TIPHE100001215/

About Us:

The Insight Partnersis a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

Contact Us:

The Insight Partners,

Phone: +1-646-491-9876

Email:sales@theinsightpartners.com

Visit link:
Live Cell Imaging Market 2019 Research Report Overview by Top Key Players, Opportunities, Key Drivers, Application and Regional Outlook To 2027 -...

Understanding the Origin of the Cell Organelle and how it is Maintained – TrendinTech

The body is a complex station that is in continuous operation morning, noon, and night. Whatever the hour, our bodies are working hard to make and maintain the various substances needed for us to operate efficiently.

Anytime a substance enters a cell it gets engulfed by some of the cells outer membrane and forms a sac as the result. This sac then becomes a carrier of the substance inside the cell. After this, the cell then merges with an organelle called an endosome.

Endosomes are often referred to as a kind of sorting station. From here the substance either gets recycled and churned back into the cell membrane or it gets thrown forward to the lysosome where it is broken down ready for degradation.

The general consensus is that these endosomes are maintained by a process which allows vesicles moving from the cell membrane to keep fusing into them. However, a recent study published in Communications Biology, suggests these vesicles are far more important than that and play a crucial role in both the formation and maintenance of endosomes.

We used our research to show that endocytic vesicle internalization is not essential, but that vesicle transport from the trans-Golgi network is crucial, states the team from the Tokyo University of Science, who is responsible for the research.

The results of the study were obtained from a series of experiments which introduced either mutations or two drugs, called Brefeldin A and Monensin, into the yeast cell. At first, mutant yeast strains were used. They chose to use these strains as they contain mutations responsible for causing defects during the endocytosis process which in turn, hamper the ingestion of substances at the cell membrane.

When looking at the mutated cells, what they discovered was the protein called Rab5, which is responsible for mediating the formation of endosomes, carried on as normal, initiating and leading normal endosome formation.

The next part of the experiment involved introducing the two drugs into the yeast cell in which to try and stop the transportation of certain vesicles. In doing this they noted that endosome formation was hampered with smaller amounts of Rab5 localized on the endosomes.

After carrying out further experiments, the leader of the study, Prof Jiro Toshima, along with his group, saw that some proteins which are already present in the Golgi or are recruited there, are those responsible for activating Rab5 and the formation of endosomes.

Gathering all the information obtained from these experiments, the team concluded that endocytosis is not required for the formation of endosomes, but the movement from the Golgi is. Our results provide a different view of endosome formation and identify the TGN as a critical location for optimal maintenance and functioning of endosomes, says Toshima. And it is this kind of knowledge that could help in the development of better treatments for a wide range of diseases.

comments

More:
Understanding the Origin of the Cell Organelle and how it is Maintained - TrendinTech

Herpes Virus Variant Linked to MS Onset – Technology Networks

Researchers at Karolinska Institutet have developed a new method to separate between two different types of a common herpes virus (HHV-6) that has been linked to multiple sclerosis. By analyzing antibodies in the blood against the most divergent proteins of herpesvirus 6A and 6B, the researchers were able to show that MS-patients carry the herpesvirus 6A to a greater extent than healthy individuals. The findings, published in Frontiers in Immunology, point to a role for HHV-6A in the development of MS.

Multiple sclerosis, MS, is an autoimmune disease that affects the central nervous system. The cause of the disease is unclear, but one plausible explanation is a virus tricks the immune system to attack the body's own tissue. Human Herpesvirus 6 (HHV-6) has previously been associated with MS, but in those studies it wasn't possible to distinguish between 6A and 6B. Through virus isolation from ill individuals, researchers have been able to show that HHV-6B can cause mild conditions such as roseola in children, but it has been unclear if HHV-6A is the cause of any disease.

According to estimates, as many as 80 percent of all children are infected with the HHV-6 virus before 2 years of age, and many also carry protection in the form of antibodies against this particular virus for the rest of their lives. But since it hasn't been possible to tell the two variants apart post-infection, it has been difficult to say whether HHV-6A or B is a risk factor for MS.

In this study, however, the researchers were able to distinguish between the A and B virus by analyzing antibodies in the blood against the proteins--immediate early protein 1A and 1B (IE1A and IE1B)--that diverge the most between the two viruses.

"This is a big breakthrough for both the MS and herpes virus research," says Anna Fogdell-Hahn, associate professor at the Department of Clinical Neuroscience at Karolinska Institutet and one of the study's senior authors. "For one, it supports the theory that HHV-6A could be a contributing factor to the development of MS. On top of that, we are now able, with this new method, to find out how common these two different types of HHV-6 are, something we haven't been able to do previously."

The researchers compared antibody levels in blood samples of some 8,700 MS-patients against more than 7,200 healthy people whose gender, date of birth, date of blood sample and other factors matched those with MS. They concluded that people with MS had a 55 percent higher risk of carrying antibodies against the HHV-6A protein than the control group. In a sub-group of almost 500 people, whose blood samples were drawn before the onset of the disease, the risk of developing MS in the future was more than doubled if they had a 6A viral infection. The younger the people were when the virus was first discovered in the blood, the higher the risk was of developing MS in the future. HHV-6B, on the other hand, was not positively associated with MS. Instead MS-patients had lower levels of antibodies toward IE1B than those without MS.

Antibodies toward Epstein-Barr virus (EBV), another herpes virus that is also associated with MS, were analyzed with the same method and the researchers were able to show that individuals affected with both viruses had an even greater risk of MS. This indicates that several virus infections could be acting jointly to increase the risk of MS.

"Both HHV-6A and 6B can infect our braincells, but they do it in slightly different ways. Therefore, it is now interesting to go forward and attempt to map out exactly how the viruses could affect the onset of MS," says Anna Fogdell-Hahn.

Reference: Engdahl, E., Gustafsson, R., Huang, J., Bistrm, M., Lima Bomfim, I., Stridh, P., Fogdell-Hahn, A. (2019). Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis. Frontiers in Immunology, 10. https://doi.org/10.3389/fimmu.2019.02715

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Go here to read the rest:
Herpes Virus Variant Linked to MS Onset - Technology Networks

Advancing cancer research – UBC Faculty of Medicine

In 2013, cancer immunotherapy was being heralded as a breakthrough in the scientific community.

This exciting development led Samantha Burugu, a recent graduate from the department of pathology and laboratory medicine, to follow her dreams of advancing cancer research.

Here she describes her PhD thesis on biomarkers in breast tumors, and shares how she is using her training to inform work with biopharmaceuticals.

Samantha Burugu is a graduate of the department of pathology and laboratory medicine.

While I was finishing up my masters degree in immunology doing foundational research, I wanted to do research that involved clinical tests conducted in hospitals. Clinical tests can be used for disease diagnoses and/or for treatment decisions. After interviewing with my doctoral thesis advisor, Dr. Torsten Nielsen, the pathology and laboratory medicine program was a clear choice. It aligned with my thesis research in biomarker development and my career aspirations.

We hear every day about increasing global incidence of cancers and that everyone in their lifetime has had, or will have, someone within their immediate circle affected by cancer. I wanted to get involved in advancing cancer research. In addition, I had trained in immunology and at the start of my program Science Magazine had just named cancer immunotherapy the 2013 Breakthrough of the Year. Cancer immunotherapy works by unleashing a patients own immune system to fight cancer and this strategy led to incredible results in some cancer patients receiving immunotherapy drugs in clinical trials.

This fall, students graduate from a range of Faculty of Medicine programs.

Read more

Although cancer immunotherapy has led to remarkable clinical results in otherwise incurable cancers, the majority of cancers do not respond to these treatments and we still have not fully elucidated the mechanisms. My doctoral thesis focused on identifying potential biomarkers in breast tumors excised from patients that would indicate a predictive ability to respond to novel cancer immunotherapy drugs.

Using conventional and novel techniques to analyze breast tumors excised from patients, I found the presence of immune cells that can be reactivated by novel immunotherapy drugs to eliminate cancer cells. This work can inform the prioritization and design of immunotherapy clinical trials for breast cancer patients.

My advice is to not be afraid to get involved in the department and try to get the most of graduate studies. By participating in different departmental committees, graduate student associations and attending professional advancement learning series (just to name a few), not only will you build a professional network but also you will develop transferable skillsets.

A healthy community for me is where you feel a sense of belonging. In that sense, you feel respected, engaged, and encouraged by the community. Everyone in a healthy community participates in their own way to make the community better.

I have recently started working at Grifols, a plasma-derived biopharmaceutical company, as a Scientific Development Manager. As part of the Medical Affairs team, I provide medical and scientific understanding of our plasma-derived therapeutic products to health care professionals and researchers.

See more here:
Advancing cancer research - UBC Faculty of Medicine

Medical student and alumni discover zebrafish are resistant to eye infection – The South End

A Wayne State University School of Medicine student and two recent graduates working on a collaborative project in the laboratories of Associate Professors of Ophthalmology, Visual and Anatomical Sciences Ashok Kumar, Ph.D., and Ryan Thummel, Ph.D., have discovered that zebrafish dont contract endophthalmitis.

The eye infection can cause blindness within hours if not diagnosed and treated quickly.

Matthew Rolain, Frank Mei, M.D. 19 and Xiao Yi Zhou, M.D. 17, contributed to the study, Zebrafish are Resistant to Staphylococcus aureus Endophthalmitis, published in Pathogens, a peer-reviewed journal in the field of microbiology and immunology.

The study showed that while humans require only 10 to 100 bugs to cause endophthalmitis, and mice require 5,000 before infection, in the freshwater fish even 250,000 bacteria wont cause the eye infection. The finding indicates that zebrafish eyes are incredibly resistant to such eye infections and possess strong host defense mechanisms.

Dr. Thummel and others in the field have shown that humans and fish share similarities in eye structure and immune responses. Studying why fish, but not human eyes, are resistant, may help identify protective pathways and molecules that could be translated to humans.

Traditionally, we have used a mouse model to study the pathobiology of these infections. In recent years, zebrafish have emerged as an important model organism in biomedical research, providing insight into the pathogenic mechanisms of infectious diseases. We sought to determine their susceptibility with the ocular bacterial infection, Dr. Kumar said. I contacted my colleague Dr. Thummel and discussed the idea, and the project took off with participation of three medical students who completed the task collectively.

Dr. Kumars laboratory focuses on understanding the pathobiology of ocular infections, especially those affecting the retina, such as endophthalmitis. The infection most often occurs due to surgical complications or eye trauma.

Apart from conducting research, I truly enjoyed mentoring these medical students, Dr. Kumar said. I hope they continue develop scientific acumen as they transition to their respective residency programs.

Matthew Rolain will graduate from the School of Medicine in 2020.

Working with Dr. Kumar and Dr. Thummel was an awesome experience, he said. They gave me great guidance and were always very supportive, regardless of the outcome of our experiments. It was nice being able to learn about the research process while working on such an interesting and potentially impactful project. Hopefully the scientific community will be able to build on our results to better help future patients.

Dr. Mei is now a resident in his transitional year in Chicago before starting a two-year Ophthalmology program at the University of Texas Southwestern Medical School in Dallas.

Individually, Drs. Kumar and Thummel were well respected in their separate expertise. However, the unification of their talents into a singular project created a collaborative environment where the strengths of both labs meshed, launching and dramatically expeditingthis project to completionin a very short timeframe. Bridging the gap between Scott Hall and the KresgeEye Institute, Drs. Kumar and Thummel created a warm atmosphere to foster my growth as a researcher. This experience was invaluableand an encouragement for me to seek further collaborations in my career in academic ophthalmology, Dr. Mei said.Lastly,I would like to thank the Medical Summer Research Project through Wayne State and the Kresge Summer Internship for supporting me through this project.

Their colleague, Dr. Zhou is a resident in her transitional year at NorthShore University Health System in Illinois. She completed a one-year fellowship at Bascom Palmer Eye Institute in Miami after graduation.

Moving forward, they plan to test zebrafish susceptibility to other bacterial and fungal pathogens.

The work was supported by grants from the National Institutes of Health (R01EY027381 and R01EY026964 to Dr. Kumar, and R01EY026551 to Dr. Thummel. Histology and imaging core resources were supported by a vision core grant (P30EY04068) and an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology, Visual and Anatomical Sciences.

Continued here:
Medical student and alumni discover zebrafish are resistant to eye infection - The South End

Cancer Immunology And Oncolytic Virology Market Opportunities and Forecast Assessment, 2021 – Downey Magazine

The globalcancer immunotherapy marketshould reach $96.5 billion by 2021 from $73.0 billion in 2016 at a compound annual growth rate (CAGR) of 5.7%, from 2016 to 2021.

Report Scope:

The scope of this report covers current cancer immunotherapy markets for most common cancers. The market segments included in this report are therapeutic monoclonal antibodies (with special focus on checkpoint inhibitors), synthetic interleukins, interferons, and colony-stimulating factors; small kinase inhibitors of cancer-related targets; protective and therapeutic cancer vaccines; and adoptive cell therapies. This report also covers treatments that are in development for late-stage and early-stage oncolytic viruses. Detailed epidemiological information, discussion of incidence and mortality trends, overview of regulatory landscapes, and analysis of market shares for leading products and companies are also included in this report.

Get More Information sample :https://www.trendsmarketresearch.com/report/sample/11805

Report Includes:

An overview of the global markets for cancer immunotherapies and oncolytic virology. Analyses of global market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021. Analyses of factors influencing market demand, such as clinical guidelines, demographic changes, and market saturation. Information covering the latest trends, market structure, market size, key drug segments, and trends in technology. Coverage of colony stimulating factors (CSFs), interferon alfa and gamma products, interleukin products and therapeutic monoclonal antibodies, including antibody conjugates, cancer vaccines, and other cancer treatment immunology products. Technological discussions, including the current state, newly issued patents, and pending applications. Profiles of leading companies in the industry.

Report Summary

Cancer is a disease with global implications. There are many different types of cancer, of which the most common types include lung, breast, colon and rectal, stomach, head and neck, prostate, cervical, melanoma, and ovarian cancer, as well as leukemia. Cancer is a genetic disease that is conventionally treated by surgery, radiation therapy, chemotherapy, hormonal therapy, and immunotherapy. Surgery is the mainstay treatment for all cancers. Usually surgery is complimented with radiation or chemotherapy to ensure the clearance of all residual cancer. Despite the advances in treatment, cancer has great plasticity; therefore, after a certain time the effects of treatment fade and cancer returns with acquired resistance. Combination therapy, using multiple modalities including surgery and pharmaceutical or radiation therapy, improves response to treatment.

Radiation and chemotherapy have many side effects. Biological treatment options provide less impactful treatment of cancer. Immunotherapy is a type of biological therapy and it incorporates elements of the immune system in cancer treatment. The immune system has various types of cells and proteins that detect and act upon signs of a disease or infection by harmful and foreign substances such as microbes, bacteria and viruses. The immune system differentiates the bodys own cells and tissues through an evolutionary bar-coding system. This system helps the immune system understand encountered foreign substances as nonself. Cancer cells are recognized as nonself as well. The immune system monitors the body for cancer and destroys when it detects a malignancy. Cancer cells can avoid being recognized by the immune system and develop resistance through numerous methods.

Request for Discount :https://www.trendsmarketresearch.com/report/discount/11805

Since the early 1900s, the connection between cancer and the immune system has caught the attention of various scientists and medical practitioners. Although the early studies were bluntly done without current technological and scientific tools, they nonetheless shed insights leading to the development of the first monoclonal antibodies and to the use of biologically derived synthetic interleukins and interferons. After many decades of research, immunotherapy finally emerged as a fully functionalclinical area in the 1990s. Since then, the cancer therapeutics landscape has changed dramatically.

With the stream of product approvals in recent years, the global immunotherapy market has reached its current value. In 2015, the global cancer immunotherapy market hit $65 billion. The current immunotherapy market contains several blockbuster products reaching their end-of-market exclusivities; however, the market is mostly comprised of newly introduced and expensive therapies. In 2016, the market expanded by more than 10% over the previous year, reaching $73 billion. During the period of 2016 through 2021, the global cancer immunotherapy market is forecast to grow by a 5.7% compound annual growth rate (CAGR), reaching $96.5 billion in 2021.

The strongest growth is expected to occur in checkpoint-inhibitor drugs with a 19.4% CAGR during the forecast period. Immunomodulators are anticipated to show the second-highest growth rates among immunotherapy products, with an 8.4% CAGR during the same period. The combined sales from both segments are expected to make up for nearly one-third of the market, with a combined sales value of $28 billion in 2021. Checkpoint inhibitors are virtually comprised of monoclonal antibodies; however,they are assessed separately due to their immense commercial and clinical significance. Sales from other therapeutic antibodies accrued to $28 billion in 2016, and this value is expected to remain relatively constant through 2021, due to several patent expiries, pressure from anticipated generic entries, and newly introduced classes of drugs expected by 2021.

Request For Report Analysis:https://www.trendsmarketresearch.com/report/analysis/BCC/cancer-immunology-and-oncolytic-virology-market

See the original post here:
Cancer Immunology And Oncolytic Virology Market Opportunities and Forecast Assessment, 2021 - Downey Magazine

Abigail Spencer and Costar Kevin McKidd Would ‘Burst Into Song’ On Grey’s Anatomy Set – PEOPLE.com

Abigail Spencer and Costar Kevin McKidd Would 'Burst Into Song' On 'Grey's Anatomy' Set | PEOPLE.com Top Navigation Close View image

Abigail Spencer and Costar Kevin McKidd Would 'Burst Into Song' On Grey's Anatomy Set

this link is to an external site that may or may not meet accessibility guidelines.

Read the original:
Abigail Spencer and Costar Kevin McKidd Would 'Burst Into Song' On Grey's Anatomy Set - PEOPLE.com

Jon Batiste: Anatomy of Angels: Live at the Village Vanguard – Relix

Jeff Tamarkin on November 27, 2019

At 35 minutes, Jon Batistes Anatomy of Angels: Live at the Village Vanguard could be described more as an EP than a full-length album but, despite its brevity, it packs in plenty of impressive musicality. Recorded at the venerable New York City jazz club with the rhythm section of bassist Phil Kuehn and drummer Joe Saylor of Stay Human, the pianists band from The Late Show with Stephen Colbert , the program features a potent battery of guest horn players. Also joining the proceedings is the always-welcome Lake Street Dive vocalist Rachael Price, who offers a sultry and bluesy ballad version of Ray Nobles chestnut The Very Thought of You. Batiste accompanies Price solo on this one, and its a most effective presentation on the slowed-down form; the pair would undoubtedly make a terrific duo on a full album or cabaret concert should that urge ever strike them. The only other cover here is an octet arrangement of Monks Round Midnight, which Batiste and his band somehow manage to give a fresh coat of New Orleans paint without losing sight of the original elements of the tune. That leaves three Batiste originals, led off by Creative, which previously launched his 2013 Jazz Is Now album and takes on an additional layer of free expression here. But its the album closing, 13-minute Anatomy of Angels that utilizes everything this collective has in their arsenal, ranging from Coltranesque manic ranting to a more subdued, blues-infused simmer.

Link:
Jon Batiste: Anatomy of Angels: Live at the Village Vanguard - Relix